Zobrazeno 1 - 10
of 27
pro vyhledávání: ''
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 12
Clin Gastroenterol Hepatol
Clin Gastroenterol Hepatol
Background & aimsPatients with Crohn's disease (CD) treated with ustekinumab who experience inadequate response, or loss of response after standard induction and/or maintenance dosing may benefit from dose escalation. We conducted a systematic review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c6178ce5b3a9a18fa70971346b665ff
https://escholarship.org/uc/item/270528g4
https://escholarship.org/uc/item/270528g4
Autor:
Christopher Young, Patricia A. Uber, Brian Di Pace, Adam Sima, Danny Issa, Sanjeev S. Solomon, Jonathan C. Hillyard, George Smallfield, Reem Z. Sharaiha
Publikováno v:
Translational gastroenterology and hepatology, vol 7, iss 0
BackgroundIntravenous erythromycin prior to endoscopy for upper gastrointestinal bleeding (GIB) improves outcomes but requires immediate preparation delaying administration in emergency cases. Azithromycin is readily available and does not require pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f0364e4c0ad91f5a58d3fd35ea3cf4
https://escholarship.org/uc/item/8f15t1zz
https://escholarship.org/uc/item/8f15t1zz
Autor:
Abdul M. Majzoub, Siddharth Singh, Rohit Loomba, Nagambika Munaganuru, Abbey Barnard, Mohammad Hassan Murad, Shravan Dave, Tarek Nayfeh
Publikováno v:
Alimentary pharmacology & therapeutics, vol 54, iss 7
Aliment Pharmacol Ther
Aliment Pharmacol Ther
Background Nonalcoholic steatohepatitis (NASH) is a common cause of chronic liver disease. There is a major need to understand the efficacy of different pharmacological agents for the treatment of NASH. Aim To assess the relative rank-order of differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfac4d3f1f81b0ef7332640a2625973d
https://escholarship.org/uc/item/16x1v6jh
https://escholarship.org/uc/item/16x1v6jh
Autor:
Kevin Kraemer, Ada O. Youk, Walid F. Gellad, Pamela S. Belperio, Hongwei Zhang, Chester B Good, Timothy R. Morgan, Shari S. Rogal, Olufunso Agbalajobi, Michael J. Fine
Publikováno v:
The American journal of gastroenterology, vol 116, iss 7
Am J Gastroenterol
Am J Gastroenterol
Introduction Although opioid use disorder (OUD) is common in patients with cirrhosis, it is unclear how medication treatment for OUD (MOUD) is used in this population. We aimed to assess the factors associated with MOUD and mortality in a cohort of V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::013ce91e928063e5de620c48a3f57f6e
https://escholarship.org/uc/item/4b8080np
https://escholarship.org/uc/item/4b8080np
Autor:
William Rosenberg, Eduardo Vilar-Gomez, Naga Chalasani, James Tonascia, Kris V. Kowdley, Laura Wilson, Veeral Ajmera, Katherine P. Yates, Samer Gawrieh, Oscar W. Cummings
Publikováno v:
Hepatology communications, vol 5, iss 5
Hepatology Communications
Hepatology Communications, Vol 5, Iss 5, Pp 786-797 (2021)
Hepatology Communications
Hepatology Communications, Vol 5, Iss 5, Pp 786-797 (2021)
Enhanced liver fibrosis score (ELF) and one of its components, amino-terminal propeptide of type III procollagen (PIIINP) are promising noninvasive biomarkers of liver histology in patients with nonalcoholic steatohepatitis (NASH). We evaluated the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf12c21617101eece01209874d3c7e0d
https://escholarship.org/uc/item/32f7b3h7
https://escholarship.org/uc/item/32f7b3h7
Autor:
Robert Battat, Ariela K. Holmer, Niels Vande Casteele, Nghia Nguyen, Brigid S. Boland, Siddharth Singh, Natalie Whitmire, Parambir S. Dulai, Amy Hemperly, William J. Sandborn, Stephanie Truong
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 19, iss 3
Clin Gastroenterol Hepatol
Clin Gastroenterol Hepatol
Background & Aims Hospitalized patients with acute severe ulcerative colitis (ASUC) often require surgery. Although the tumor necrosis factor antagonist infliximab is an effective salvage therapy to prevent colectomy in patients with ASUC, optimal do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ef35fa5a256cbfce82b22e73584dc04
https://escholarship.org/uc/item/5672x7n8
https://escholarship.org/uc/item/5672x7n8
Publikováno v:
Liver research, vol 4, iss 4
Liver research
Liver Research, Vol 4, Iss 4, Pp 168-172 (2020)
Liver research
Liver Research, Vol 4, Iss 4, Pp 168-172 (2020)
Hepatocellular carcinoma (HCC) is a malignant tumor with a fairly poor prognosis (5-year survival of less than 50%). Using sorafenib, the only food and drug administration (FDA)-approved drug, HCC cannot be effectively treated; it can only be control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38a9063a0988099838b02800a1603f88
https://escholarship.org/uc/item/6cp3q81q
https://escholarship.org/uc/item/6cp3q81q
Autor:
James A. Proudfoot, Brian G. Feagan, Ronghui Xu, William J. Sandborn, Vipul Jairath, Parambir S. Dulai, Siddharth Singh
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 18, iss 2
Clin Gastroenterol Hepatol
Clin Gastroenterol Hepatol
BACKGROUND & AIMS: With several options available for patients with moderate–severe ulcerative colitis (UC), rapidity of symptom resolution could be an important differentiator. We compared the efficacy and speed of onset of action of infliximab vs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e2641b67528e452614765ad57cff59
https://escholarship.org/uc/item/82n7t9j5
https://escholarship.org/uc/item/82n7t9j5
Autor:
Gary W. Falk, Amindra S. Arora, Sami R. Achem, Gail M. Comer, Sandeep K. Gupta, Ekaterina Safroneeva, Yvonne Romero, James J. Lee, Joseph H. Butterfield, Francisco C. Ramirez, Alex Straumann, Dawn L. Francis, Glenn T. Furuta, Catherine R. Weiler, Benjamin Enav, Javed Sheikh, Tsung-Teh Wu, Evan S. Dellon, John T. Woosley, John M. Wo, Kaiser G. Lim, John C. Lewis, Amir F. Kagalwalla, Diana M. Orbelo, Thomas C. Smyrk, Joseph A. Murray, Mirna Chehade, Ikuo Hirano, Oral Alpan, Éric Drouin, Michael D. Crowell, Murli Krishna, Cuong C. Nguyen, Lucinda A. Harris, David A. Katzka, John Leung, David E. Fleischer, Christian Bussmann, Sarah B. Umar, Amy E. Foxx-Orenstein, Felicity Enders, David Hafner, Alain M. Schoepfer, Michael Coslovsky, Margaret H. Collins, Kenneth R. DeVault, Kathleen J. Yost, Robert O. Newbury, Guang Yu Yang, Marcel Zwahlen, Gordon H. Guyatt, Seema S. Aceves, Nirmala Gonsalves, Hirohito Kita, Marie C. Roumet, Brian A. Meltzer, Jonathan M. Spergel, G. Richard Locke, Shabana F. Pasha, Stephen Attwood, Claudia E. Kuehni, David Armstrong, Jeffrey A. Alexander
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 17, iss 8
Background & Aims Eosinophilic esophagitis (EoE) is assessed endoscopically (endoscopic activity), based on grades of edema, rings, exudates, furrows, and strictures (EREFS). We examined variations in endoscopic assessments of severity, developed and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::849ebaaa7d17828da1926baeebf93a6d
https://escholarship.org/uc/item/594849mk
https://escholarship.org/uc/item/594849mk
Autor:
Leroy R. Thacker, Hugo E. Vargas, Ram Subramanian, Scott W. Biggins, Paul J. Thuluvath, Jasmohan S. Bajaj, Puneeta Tandon, Patrick S. Kamath, Jennifer C. Lai, Guadalupe Garcia-Tsao, Florence Wong, Benedict Maliakkal, Jacqueline G. O'Leary, Michael B. Fallon, K. Rajender Reddy
Publikováno v:
Alimentary pharmacology & therapeutics, vol 49, iss 12
Aliment Pharmacol Ther
Aliment Pharmacol Ther
BackgroundHepatic encephalopathy (HE) can adversely affect outcomes in both in-patients and out-patients with cirrhosis.AimTo define targets for improving quality of care in HE management in the multi-centre North American Consortium for End-Stage Li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f4dfcf379405de4b5059eb38d0f250a
https://escholarship.org/uc/item/93x8d1vp
https://escholarship.org/uc/item/93x8d1vp